Delivery Order SPE2DB22D3501-SPE2DB24FUN75
Award Date
2/12/24
Potential Completion Date
2/13/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $28,627.71 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CATHFLO ACTIVASE 2 MG VIALS. The contract has a completion date of May 10, 2022 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, with no major subcontractors mentioned. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $5,769.87 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This contract is for the delivery of 100 mg vials of the pharmaceutical product ACTIVASE. The contract has a firm fixed price and does not utilize any set-aside designations. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This federal contract award is between the U.S. Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $9,039.44, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA. The IDC, worth up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $13,820.29 by the Defense Logistics Agency Troop Support Medical to provide 2 mg vials of Cathflo Activase, a thrombolytic medication used to treat heart attacks and strokes. Performance will take place in Conshohocken, Pennsylvania under the agency's indefinite-delivery/indefinite-quantity Prime Vendor contract to supply pharmaceuticals and...
This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical sourcing and distribution company. The $6,783.73 firm fixed price delivery order is for the supply of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product. The contract has a completion date of December 22, 2023. Amerisourcebergen Drug Corp has received numerous prior contract awards from DLA Troop...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $4,666.30 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide CATHFLO ACTIVASE 2 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The $15,945.76 firm fixed price delivery order has a completion date of January 17, 2024 and was awarded on January 16, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is a prime contractor that has received numerous DLA Troop Support...
This federal contract award is for the delivery of Cathflo Activase 2 mg vials, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $7,313.27 and an ultimate completion date of May 1, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $28,484.84 and an ultimate completion date of May 23, 2025. The contract provides for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, to be performed at a location in Conshohocken, Pennsylvania. This contract is not set-aside and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,157.38, is for the delivery of 4,567,908,517 units of the medication Cathflo Activase 2 mg vials. The contract has a firm fixed price pricing type and an ultimate completion date of April 15, 2025. There is no set-aside designation noted for this award. AmerisourceBergen holds a...